Author

M.-S. Park

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

H. Park· 2 shared B. M. Kang· 1 shared C. Ju· 1 shared D. Kim· 1 shared G. E. Lee· 1 shared H.-J. Kwon· 1 shared J. Cho· 1 shared J. I. Kim· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

H. Park

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Analysis of spike protein variants evolved in a novel mouse model of persistent SARS-CoV-2 infection

D. Kim, J. Kim, M. Kim, H. Park, S. Maharjan, K. Baek, B. M. Kang, S. Kim, S. Park, M.-S. Park, Y. Lee, H.-J. Kwon

The paper establishes a novel mouse model of persistent SARS-CoV-2 infection using Calu-3 xenografts and identifies spike protein mutations that enhance viral replication and host adaptation.

bioRxiv · Mar 19, 2023 · PreprintMicrobiology

Pyronaridine and artesunate are potential antiviral drugs against COVID-19 and influenza

J.-Y. Bae, G. E. Lee, H. Park, J. Cho, Y.-E. Kim, J.-Y. Lee, C. Ju, W.-K. Kim, J. I. Kim, M.-S. Park

This study identifies pyronaridine and artesunate as potential antiviral drugs effective against SARS-CoV-2 and influenza viruses in human lung cells.

bioRxiv · Jul 28, 2020 · PreprintMicrobiology